# AMTE Power proposed £5 million convertible bond facility

- Link: https://www.directorstalkinterviews.com/amte-power-proposed-5-million-convertible-bond-facility/4121086787
- Published: 2022-10-17T07:06:16+01:00
- Author: Giles

AMTE Power Plc ([LON:AMTE](https://www.directorstalkinterviews.com/company/amte-power-plc/amte.l)),
a leading developer and manufacturer of lithium-ion and sodium-ion battery cells
for specialist markets, today announced that  it has signed non-binding heads of
terms to enter into a proposed £5 million convertible bond facility with Arena Investors,
LP.

The Proposed Facility follows the recent signing of a production contract with the
UK Battery Industrialisation Centre (**“UKBIC”**), announced on 6^(th) October 2022,
for the Company’s six minute re-chargeable Ultra High Power cells, and it is expected
that the Proposed Facility would give the Company the financial capability to secure
and execute on production contracts for both these, and other cells to be produced
at Thurso.  The Proposed Facility would also provide general working capital for
the Group into the second quarter of 2023, at which point it anticipates producing
cells under customer production contracts at the UKBIC.

**Use of funding**

Further to the uses outlined in the paragraph above, the Proposed Facility would
also be used to enable the Group to:

·    conclude the development for initial commercialisation of each of its core 
cells: the Ultra High Power, the Ultra Safe and the Ultra Prime; and

·     meet the operating costs and capital expenditure required to produce and sell
into the Company’s target markets:

o  the Ultra High Power cell, which is expected to commence commercial production
at the UKBIC in early 2023;

o  the Ultra Safe cell, which is expected to commence commercial production at Thurso
in 2023; and

o  the Ultra Prime cell, which is expected to be produced for initial supply in 
2023, with commercial production anticipated at Thurso in 2024.

**Details of the Proposed Facility**

Under the Heads of Terms^([1]), Arena would provide an interest free, unsecured 
bond facility to the Company for a total amount of up to £5 million, available for
drawdown in three tranches: £3 million on completion of the Proposed Facility and
two further tranches of £1 million each at least 60 days following drawdown of the
previous tranche, provided that no more than £4 million is outstanding under the
Proposed Facility at the relevant time. The subscription price payable by Arena 
would amount to 92 per cent. of the principal value of each tranche. It is further
anticipated that the Company would pay an upfront fee equal to 3 per cent. of the
Proposed Facility which would be deducted from the first drawdown tranche.

Arena would be entitled to convert outstanding amounts (in minimum instalments of
£150,000) under the Proposed Facility into new ordinary shares of 0.5 pence each
in the capital of the Company, at a price per share equal to 95 per cent. of the
3-lowest daily volume weighted average prices over a 15-trading day look back period(**“
VWAP”**) prior to the date of its conversion notice. Any amounts not so converted
would become repayable on the second anniversary of drawdown.

Arena would be unable to convert any amounts outstanding under the Proposed Facility
where such conversion would mean that it would become interested (as defined in 
the City Code on Takeovers and Mergers) in more than 29.9 per cent. of the Ordinary
Shares, save in circumstances where such conversion is conditional upon the Company’s
independent shareholders waiving the obligation on Arena to make a mandatory bid
for the remaining Ordinary Shares under Rule 9 of the Takeover Code.

In addition, Arena would be entitled to receive warrants, exercisable until the 
third anniversary of the Proposed Facility, to subscribe for £1.5 million of new
Ordinary Shares at a price of 82.04 pence per Ordinary Share, representing a premium
of 20 per cent. to the VWAP on 14 October 2022.

The Proposed Facility would be capable of redemption in cash at any time by the 
Company at 115 per cent. of the principal amount then outstanding.

It is expected that the Proposed Facility will contain certain covenants, representations
and warranties and events of default typical for a facility of this type and size.

Under the Heads of Terms, the Company has agreed, subject to limited exceptions,
not to solicit, accept or encourage any other debt or convertible financing proposal
with respect to the Proposed Facility for a period of 60 days following the entry
into the Heads of Terms.  Further, the Company, in the event of breaching such exclusivity
provision, shall pay Arena’s costs and expenses.

It is intended that definitive and legally binding contractual documentation (the**“
Definitive Documents”**), incorporating the summary terms referenced above, will
be entered into as soon as reasonably practicable.  Further, the entry into Definitive
Documents is conditional upon, amongst other things, the conclusion of due diligence
satisfactory to Arena, there being no material adverse change to the Group and Arena
remaining satisfied with the financial performance of the Company, the Company’s
shareholders approving certain shareholder resolutions (the **“Resolutions”**) required
to implement the Proposed Facility at a general meeting of shareholders (the **“
General Meeting”**) and other conditions which are customary for a facility of this
type.

**Accordingly, there can be no guarantee that the Definitive Documents will be entered
into or that the Proposed Facility becomes unconditional in which event the Company
would not receive the funding under the Proposed Facility.**

The Proposed Facility will provide funds for the Group as outlined above and will
supersede alternative funding options which the Group has been exploring to support
its growing commercial cell production requirements.

**Shareholder approval and importance of the vote**

In order to provide the Company with the flexibility to be able to enter into Definitive
Documents as soon as possible, the Company proposes to despatch a shareholder circular(
the **“Circular”**) containing details of the Proposed Facility and convening the
General Meeting in order to pass the Resolutions, on or around 17 October 2022. 
The Circular, once published, will be available on the Company’s website at www.
amtepower.com/investors.

**Shareholders should be aware that, if for any reason (including the Resolutions
not being passed at the General Meeting), the Definitive Documents in respect of
the Proposed Facility are not entered into or the Proposed Facility does not become
unconditional, the Company would need to consider the options available to it in
terms of alternative sources of funding. It may be that such sources would not be
available or available on favourable terms.  Accordingly, if alternative sources
of funding anticipated by the Board could not be secured, the Company expects that
it would not have sufficient cash for its current level of activities beyond November
2022.**

^([1]) Which are non-binding save in respect of exclusivity, expenses, governing
law, confidentiality and indemnification.

Share on:
